X4 Pharmaceuticals Inc Sustainability Reports
X4 Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company focused on developing and commercializing novel therapeutics for rare diseases of the immune system and rare cancers.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300R0UFVPXWP86U94
FIGI: BBG001TCY1B7
2 reports from 2023 to 2025